Genmab — Januar 2020
-
-
Horizon Therapeutics is increasing its peak U.S. annual net sales expectation to more than $1 billion, from the previous expectation of more than $750 million. https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-increases-peak-us-annual-net-sales
-
AMERIKANSK FINANSHUS STARTER DÆKNING AF GENMAB OG ANBEFALER KØB
16:22
Amerikanske Suntrust har indledt dækning af biotekselskabet Genmab.Det sker med anbefalingen køb og en pris på 28 dollar per depotbevis, ADR.
Det fremgår af data fra Bloomberg News.
Genmabs ADR ligger mandag eftermiddag i 22,47 dollar på børsen i New York.
/ritzau/FINANS
Charlotte Mackeprang
RITZAU
-DR5/DR5) Enrollment: raised from 188 to 520 [Anticipated] ?? That is a huge increase... Maybe it is a typo and should be 250?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind